| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Dec 18, 2013
Perrigo Company plc (NYSE: PRGO) today announced the appointment of its Board of Directors, effective until Perrigo Company's annual general meeting...
-
Dec 18, 2013
Perrigo Company plc (NYSE, TASE: PRGO) ("Perrigo") and Elan Corporation, plc ("Elan") today announced that Perrigo has completed the acquisition of Elan in a...
-
Dec 13, 2013
Perrigo Company (NYSE: PRGO; TASE) and Elan Corporation, plc (NYSE: ELN) ("Elan") today announced that the Irish High Court has approved...
-
Nov 21, 2013
Perrigo Company (NYSE, TASE: PRGO) today announced that, in connection with its offer to purchase for cash (the "Tender Offer") any and all of its...
-
Nov 20, 2013
Perrigo Company (NYSE: PRGO;TASE) announced that it has filed with the U.S. Food and Drug Administration (FDA) an Abbreviated New Drug Application...
-
Nov 18, 2013
Perrigo Company (NYSE: PRGO; TASE), a leading global healthcare supplier ("Perrigo") today announced that, at a shareholder meeting held today,...
-
Nov 6, 2013
Perrigo Company (NYSE: PRGO;TASE) today announced that its Board of Directors declared a quarterly dividend of $0.09 per share, payable on December...
-
Nov 1, 2013
The Perrigo Company (NYSE: PRGO; TASE) announced today that it has initiated a voluntary, nationwide product recall to the retail level of 18 batches...
-
Oct 31, 2013-- Fiscal first quarter net sales of $933 million, up 21%.
Perrigo Company (NYSE: PRGO; TASE) today announced results for its first quarter ended September 28, 2013. (Logo: ...
-
Oct 24, 2013
In the news release, Perrigo Company To Release First Quarter Fiscal Year 2014 Results On October 31, 2013, issued Oct. 24, 2013 by Perrigo Company over PR Newswire, we are advised by the company...
-
Oct 9, 2013
Perrigo Company (NYSE, TASE: PRGO) today announced that it has scheduled a shareholder meeting for Monday, November 18, 2013 in connection with...
-
Sep 23, 2013
Perrigo Company (NYSE: PRGO; TASE) today announced that it has received final approval for its abbreviated new drug application for nitroglycerin...
-
Sep 20, 2013
PetArmor®, known for its veterinarian-quality products that protect dogs and cats from fleas and ticks, is now also helping to protect four legged K-9s...
-
Sep 20, 2013
Perrigo Company (NYSE: PRGO; TASE) today announced the appointment of Keith Webber as Head of Regulatory Review, effective October 21, 2013. This...
-
Sep 10, 2013
Perrigo Company (NYSE: PRGO; TASE) today announced that it has received final approval from the U.S. Food and Drug Administration for its...
-
Sep 10, 2013
Perrigo Company (NYSE: PRGO; TASE) today announced that Perrigo Chairman, President and CEO Joseph C. Papa will present at the Morgan Stanley Global...
-
Aug 15, 2013- Fiscal fourth quarter net sales increased $135 million, or 16%, to $967 million.
Perrigo Company (NYSE: PRGO; TASE: PRGO) today announced results for its fourth quarter and fiscal year ended June 29, 2013. (Logo:...
-
Aug 14, 2013
Perrigo Company (NYSE: PRGO;TASE) today announced that its Board of Directors declared a quarterly dividend of $0.09 per share, payable on September...
-
Aug 12, 2013
Perrigo Company (NYSE: PRGO; TASE) today announced that it has received final approval from the U.S. Food and Drug Administration for its abbreviated...
-
Aug 12, 2013
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) and Perrigo Company (NYSE: PRGO;TASE) today announced the launch of the generic...
-
Aug 5, 2013
Perrigo Company (NYSE: PRGO; TASE) today announced that its infant formula division, Perrigo Nutritionals, is working with the American Academy of...
-
Aug 2, 2013Company also Announces Plans to Conduct its Analyst Day After Completion of Elan Corporation Acquisition
Perrigo Company (NYSE: PRGO, "Perrigo") today announced that it it will release financial results for its fourth quarter and fiscal year 2013 and...
-
Jul 31, 2013
Perrigo Company (NYSE: PRGO; TASE) today announced that it has received final approval for its abbreviated new drug application for fluticasone...
-
Jul 29, 2013- Establishes a differentiated platform for further international expansion
– Short Form – Rule 2.5 Announcement – Fact Sheet – Conference Call Slides